International Psoriasis Council

Advancing Knowledge. Improving Care.

Panel Discussion: From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis and Eczema

Tiago Torres, MD, PhD | Portugal
Johann Gudjonsson, MD, PhD | United States
Michel Gilliet, MD | Switzerland
Sara Brown, MBChB, MD | United Kingdom

Featured Experts

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026